Dandelion Seed Extract Affects Tumor Progression and Enhances the Sensitivity of Cisplatin in Esophageal Squamous Cell Carcinoma

被引:5
|
作者
Li, Yuxi [1 ]
Deng, Yuying [1 ]
Zhang, Xiuli [2 ]
Fu, Han [1 ]
Han, Xue [1 ]
Guo, Wenqing [1 ]
Zhao, Wei [1 ]
Zhao, Xuening [1 ]
Yu, Chunxue [1 ]
Li, Hui [3 ]
Lei, Kaijian [1 ]
Wang, Tianxiao [1 ]
机构
[1] Henan Univ, Sch Pharm, Kaifeng, Peoples R China
[2] Liaoning Agr Coll, Dept Bot, Yingkou, Peoples R China
[3] Henan Univ, Sch Basic Med Sci, Joint Natl Lab Antibody Drug Engn, Kaifeng, Peoples R China
基金
中国国家自然科学基金;
关键词
dandelion seed extract; ESCC; tumor progression; cisplatin; sensitivity; CANCER STATISTICS; METASTASIS; SURVIVIN;
D O I
10.3389/fphar.2022.897465
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Like dandelion, dandelion seed also have anti-inflammatory activity. Therefore, in this article, we intend to explore the anti-cancer availability of aqueous dandelion seed extract (DSE) in esophageal squamous cell carcinoma (ESCC). Firstly, the effects of DSE on cell proliferation, apoptosis, migration, invasion and angiogenesis were investigated. Then to explore the mechanism of DSE against ESCC, the levels of proliferation-associated proteins (PI3K, Akt and pAkt), apoptosis-associated proteins (survivin, Bcl-2, Bax, caspase3 and caspase9), metastasis-associated proteins (MMP2, MMP9, VEGF) and EMT progression-associated proteins (Snail, E-cadherin and Vimentin) were analyzed. Next, we further explored the effect of DSE on the sensitivity of cisplatin (DDP) in ESCC cells and investigated the effect of DSE combined with DDP on DNA damage repair-associated proteins (MSH2, MLH1 and ERCC1) and drug resistant target protein STAT3. The results indicated that DSE selectively inhibited cell growth, proliferation, migration, invasion, angiogenesis and induced cell apoptosis in ESCC cells. It was observed the decreased PI3K, Akt and pAkt proteins levels in KYSE450 and Eca109 cells administrated with DSE. The data also showed that the application of DSE decreased the level of survivin and the ratio of Bcl-2/Bax, while increased the levels of caspase3 and caspase9. We also observed that DSE significantly decreased the levels of MMP2, MMP9 and VEGF proteins and inhibited the EMT progression in KYSE450 and Eca109 cells. In addition, survivin plays a critical role in DSE against ESCC followed with the application of survivin inhibitor YM155 impairing the inhibitory abilities of DSE in ESCC cells. Meanwhile, it was observed that DSE enhances the sensitivity of DDP to human ESCC cells via promoting DNA damage and inhibiting phosphorylation of STAT3. Therefore, DSE may affect ESCC progression and enhance the sensitivity of cisplatin, and consequently become an effective anti-cancer option for human ESCC treatment.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Tumor progression and chemoradiosensitivity in relation to the expression of apoptosis related proteins in esophageal squamous cell carcinoma
    Tsujitani, S.
    Saito, H.
    Tatebe, S.
    Ikeguchi, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [32] Bcl-X expression in esophageal squamous cell carcinoma: Association with tumor progression and prognosis
    Takayama, T
    Nagao, M
    Sawada, H
    Yamada, Y
    Emoto, K
    Fujimoto, H
    Ueno, M
    Hirao, S
    Nakajima, Y
    JOURNAL OF SURGICAL ONCOLOGY, 2001, 78 (02) : 116 - 123
  • [33] Esophageal squamous cell carcinoma presenting as a submucosal tumor
    Yang, Lin
    Zuo, Zeping
    Zhang, Hanlu
    Chen, Longqi
    ASIAN JOURNAL OF SURGERY, 2023, 46 (08) : 3075 - 3076
  • [34] Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer
    Guo, Jianfeng
    Zhu, Yapei
    Yu, Lili
    Li, Yuan
    Guo, Jing
    Cai, Jing
    Liu, Lin
    Wang, Zehua
    PEERJ, 2021, 9
  • [35] Targeting the mitochondrial calcium uniporter inhibits cancer progression and alleviates cisplatin resistance in esophageal squamous cell carcinoma
    Miao, Yu
    Wang, Xiaofei
    Lai, Yafang
    Huang, Ying
    Yin, Hua
    Meng, Xiangkun
    Liu, Hao
    Hou, Ruirui
    Lin, Wan
    Zhang, Xiaoxu
    Zhang, Xu
    Chai, Bei Cho
    Zhang, Feixiong
    Guo, Le
    Yang, Shaoqi
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2023, 63 (01) : 1 - 16
  • [36] Butyrate response factor 1 enhances cisplatin sensitivity in human head and neck squamous cell carcinoma cell lines
    Lee, SK
    Kim, SB
    Kim, JS
    Moon, CH
    Han, MS
    Lee, BJ
    Chung, DK
    Min, YJ
    Park, JH
    Choi, DH
    Cho, HR
    Park, SK
    Park, JW
    INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (01) : 32 - 40
  • [37] Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma
    Li, Xia
    Zhao, Lihong
    Wei, Mengke
    Lv, Jiali
    Sun, Yawen
    Shen, Xiaotao
    Zhao, Deli
    Xue, Fuzhong
    Zhang, Tao
    Wang, Jialin
    JOURNAL OF CANCER, 2021, 12 (11): : 3190 - 3197
  • [38] Role of stromal fibroblasts in the progression of esophageal squamous cell carcinoma
    Saito, Shin
    Morishima, Kazue
    Matsubara, Daisuke
    Hosoya, Yoshinori
    Sata, Naohiro
    Yasuda, Yoshikazu
    Niki, Toshiro
    CANCER RESEARCH, 2012, 72
  • [39] MicroRNA-544 inhibits esophageal squamous cell carcinoma cell proliferation and enhances sensitivity to cisplatin by repressing E2F transcription factor 5
    Sun, Fengrong
    Zhang, Cuiping
    Ma, Deliang
    Wang, Kai
    ONCOLOGY LETTERS, 2019, 18 (04) : 4203 - 4209
  • [40] Silencing Rab14 represses the proliferation and migration of oral squamous cell carcinoma, and enhances cisplatin sensitivity
    Lian, Qing
    Ma, Dong-Mei
    Chen, Ming-Gang
    Chen, Ke
    Li, Xiang-Jun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2017, 9 (09): : 4195 - 4205